103 related articles for article (PubMed ID: 11282391)
1. Inotrophic effects of the K(+) channel blocker TEA on dystrophic (mdx and dy/dy) mouse diaphragm.
van Lunteren E; Manubay P
Respir Physiol; 2001 Apr; 125(3):249-54. PubMed ID: 11282391
[TBL] [Abstract][Full Text] [Related]
2. Effects on dystrophic (dy/dy) limb muscle of the K+ channel blocker tetraethylammonium.
Manubay P; van Lunteren E
Neurosci Lett; 2000 Apr; 283(3):169-72. PubMed ID: 10754214
[TBL] [Abstract][Full Text] [Related]
3. Improvement of dy/dy dystrophic diaphragm by 3,4-diaminopyridine.
van Lunteren E; Moyer M
Muscle Nerve; 2002 Jul; 26(1):71-8. PubMed ID: 12115951
[TBL] [Abstract][Full Text] [Related]
4. Reduced fatigue in diaphragm muscle of merosin-deficient DY/DY dystrophic mice.
van Lunteren E; Moyer M
Respiration; 2003; 70(6):636-42. PubMed ID: 14732796
[TBL] [Abstract][Full Text] [Related]
5. Sternohyoid muscle fatigue properties of dy/dy dystrophic mice, an animal model of merosin-deficient congenital muscular dystrophy.
van Lunteren E; Moyer M
Pediatr Res; 2003 Oct; 54(4):547-53. PubMed ID: 12840158
[TBL] [Abstract][Full Text] [Related]
6. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
[TBL] [Abstract][Full Text] [Related]
7. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.
Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR
Neuromuscul Disord; 2001 Nov; 11(8):703-12. PubMed ID: 11595512
[TBL] [Abstract][Full Text] [Related]
8. A comparative freeze-fracture study of plasma membrane of dystrophic skeletal muscles in dy/dy mice with merosin (laminin 2) deficiency and mdx mice with dystrophin deficiency.
Shibuya S; Wakayama Y; Oniki H; Kojima H; Saito M; Etou T; Nonaka I
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):123-31. PubMed ID: 9160897
[TBL] [Abstract][Full Text] [Related]
9. Perchlorate differentially potentiates excitation-contraction coupling of diaphragm muscle from mdx and control mice.
Péréon Y; Khammari A; Noireaud J
Acta Physiol Scand; 1996 Nov; 158(3):287-94. PubMed ID: 8931772
[TBL] [Abstract][Full Text] [Related]
10. Isotonic fatigue in laminin alpha2-deficient dy/dy dystrophic mouse diaphragm.
Pollarine J; Moyer M; Van Lunteren E
Muscle Nerve; 2007 Nov; 36(5):672-8. PubMed ID: 17661374
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid therapy does not alter the threshold for contraction-induced injury in dystrophic (mdx) mouse diaphragm.
Yang L; Luo J; Petrof BJ
Muscle Nerve; 1998 Mar; 21(3):394-7. PubMed ID: 9486869
[TBL] [Abstract][Full Text] [Related]
12. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
13. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Neuromuscul Disord; 2001 Mar; 11(2):192-6. PubMed ID: 11257477
[TBL] [Abstract][Full Text] [Related]
14. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
[TBL] [Abstract][Full Text] [Related]
15. Combined XIL-6R and urocortin-2 treatment restores MDX diaphragm muscle force.
Manning J; Buckley MM; O'Halloran KD; O'Malley D
Muscle Nerve; 2017 Dec; 56(6):E134-E140. PubMed ID: 28294390
[TBL] [Abstract][Full Text] [Related]
16. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.
Gregorevic P; Plant DR; Leeding KS; Bach LA; Lynch GS
Am J Pathol; 2002 Dec; 161(6):2263-72. PubMed ID: 12466140
[TBL] [Abstract][Full Text] [Related]
17. Nutraceutical and pharmaceutical cocktails did not preserve diaphragm muscle function or reduce muscle damage in D2-mdx mice.
Spaulding HR; Quindry T; Quindry JC; Selsby JT
Exp Physiol; 2020 Jun; 105(6):989-999. PubMed ID: 32267561
[TBL] [Abstract][Full Text] [Related]
18. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of diaphragm muscle in alpha2-laminin (merosin)-deficient dy/dy dystrophic mice.
van Lunteren E; Moyer M; Leahy P
Physiol Genomics; 2006 Mar; 25(1):85-95. PubMed ID: 16368874
[TBL] [Abstract][Full Text] [Related]
20. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
Hayes A; Williams DA
Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
